跳转至内容
Merck
CN

162558

4-氟-2-硝基苯胺

97%

登录 查看组织和合同定价。

选择尺寸


关于此项目

线性分子式:
FC6H3(NO2)NH2
化学文摘社编号:
分子量:
156.11
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
206-666-0
Beilstein/REAXYS Number:
2210197
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

4-氟-2-硝基苯胺, 97%

InChI key

PUGDHSSOXPHLPT-UHFFFAOYSA-N

InChI

1S/C6H5FN2O2/c7-4-1-2-5(8)6(3-4)9(10)11/h1-3H,8H2

SMILES string

Nc1ccc(F)cc1[N+]([O-])=O

assay

97%

mp

90-94 °C (lit.)

functional group

fluoro
nitro

正在寻找类似产品? 访问 产品对比指南

Application

4-Fluoro-2-nitroaniline was used as starting reagent in the synthesis of 4-fluoro-N-ethyl-2-nitroaniline and N-(4-fluoro-2-nitrophenyl)-β-alanine.

General description

4-Fluoro-2-nitroaniline forms complexes with cobalt(II), nickel(II) and copper(II).

pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

192.2 °F - closed cup

flash_point_c

89 °C - closed cup

ppe

dust mask type N95 (US), Eyeshields, Gloves

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Thomas Hussenether et al.
Bioorganic & medicinal chemistry, 12(10), 2625-2637 (2004-04-28)
Novel 4-arylpiperazin-1-yl-substituted 2,3-dihydro-1H-1,4- and 1H-1,5-benzodiazepines and their aza-analogues were synthesized as debenzoclozapine derivatives for evaluation as potential D4-ligands. While Ki values of some of the title compounds came within the range of clozapine, they showed an impressively greater selectivity over
Complexes of copper (II), nickel (II) and cobalt (II) with 2-fluoro, 5-nitroaniline and 4-fluoro, 2-nitroaniline.
DeVoto G, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy, 38(7), 725-728 (1982)
S Singh et al.
The Journal of pharmacology and experimental therapeutics, 296(2), 600-611 (2001-02-13)
The diseases of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) are characterized by mucus-congested airways. Agents that stimulate the secretion of Cl- are anticipated to facilitate mucociliary clearance and thus be of benefit in the treatment of CF

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持